Loading...
NYSE: IQV
IQVIA Holdings Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2017
Market Cap
$28.06B
52w High
$247.05
52w Low
$134.65
P/E
20.67
Volume
357.02K
Outstanding Shares
169.70M
Company profile
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.
CEOAri Bousbib
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees89,000
IPO dateMay 9, 2013
Valuation
Forward P/E—
EV/EBITDA15.28
Enterprise value$52.94B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth10.26%
Gross margin26.28%▼24.69%vs FY2024
Operating margin14.02%▼1.90%vs FY2024
ROE20.91%▼7.59%vs FY2024
Analyst consensus
RatingBuy
Target price$233.80▲41.41%
37
Buy
6
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.81
$2.77
Q3FY25
ActualEst.
$3.00
$2.98
Q4FY25
ActualEst.
$3.42
$3.40
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$4.02B
$3.97B
Q3FY25
ActualEst.
$4.1B
$4.08B
Q4FY25
ActualEst.
$4.36B
$4.24B
Q1FY26
Next Est.
—